Of The University Of California Regents

Holdings History for Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA)

Symbol: NTLA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2024		-1.4%	$0	0	-117,315	-100%	$14.28	Q3 2024
30 Jun 2024	1.4%	0%	$2,625,510	117,315	0		$22.38	Q2 2024
31 Mar 2024	0.94%	0%	$3,227,336	117,315	0		$27.51	Q1 2024
31 Dec 2023	0.45%	+0.02%	$3,576,934	117,315	+5,875	+5.3%	$30.49	Q4 2023
30 Sep 2023	0.45%	0%	$3,523,733	111,440	0		$31.62	Q3 2023
30 Jun 2023	0.57%	0%	$4,544,523	111,440	0		$40.78	Q2 2023
31 Mar 2023	0.77%	0%	$4,153,369	111,440	0		$37.27	Q1 2023
31 Dec 2022	0.74%	0%	$3,888,142	111,440	0		$34.89	Q4 2022
30 Sep 2022	1.3%	0%	$6,236,000	111,440	0		$55.96	Q3 2022
30 Jun 2022	1.2%	0%	$5,768,000	111,440	0		$51.76	Q2 2022
31 Mar 2022	1.2%	0%	$8,098,000	111,440	0		$72.67	Q1 2022
31 Dec 2021	1.8%	0%	$13,177,000	111,440	0		$118.24	Q4 2021
30 Sep 2021	1.8%	0%	$14,950,000	111,440	0		$134.15	Q3 2021
30 Jun 2021	2.3%	0%	$18,043,000	111,440	0		$161.91	Q2 2021
31 Mar 2021	1.2%	0%	$8,944,000	111,440	0		$80.26	Q1 2021
31 Dec 2020	0.88%	0%	$6,062,000	111,440	0		$54.40	Q4 2020
30 Sep 2020	0.31%	0%	$2,215,000	111,440	0		$19.88	Q3 2020
30 Jun 2020	0.33%	0%	$2,342,000	111,440	0		$21.02	Q2 2020
31 Mar 2020	0.2%	0%	$1,363,000	111,440	0		$12.23	Q1 2020
31 Dec 2019	0.86%	0%	$1,635,000	111,440	0		$14.67	Q4 2019
30 Sep 2019	2.8%	0%	$1,488,000	111,440	0		$13.35	Q3 2019
30 Jun 2019	5.2%	0%	$1,824,000	111,440	0		$16.37	Q2 2019
31 Mar 2019		0%	$11,060,000	524,423	0		$21.09 ^*	Q1 2019
31 Dec 2018	17%	0%	$7,158,000	524,423	0		$13.65	Q4 2018
30 Sep 2018	29%	0%	$15,009,000	524,423	0		$28.62	Q3 2018
30 Jun 2018	38%	0%	$14,348,000	524,423	0		$27.36	Q2 2018
31 Mar 2018	20%	0%	$11,060,000	524,423	0		$21.09	Q1 2018
31 Dec 2017	15%	+15%	$10,079,000	524,423	+524,423	NEW	$19.22	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.